| Product Name | MF | CAS | Details |
|---|
| Gold Colloid (250 nm) | Details |
| Methyl mandelate glucoside | C15H20O8 | Details |
| N,N,4-Trimethyl-1,3-thiazol-2-amine | C6H10N2S | 6142-18-3 | Details |
| (1S)-1-(5-Bromo-2,3-dihydro-1-benzofuran-7-yl)ethan-1-ol | C10H11BrO2 | 1568216-96-5 | Details |
| 1,2-Naphthoquinone-4-sulfonic acid sodium salt | C10H5NaO5S | 521-24-4 | Details |
| H-GLHTSATNLYLH-NH2 | Details |
| 3-Amino-6-(trifluoromethyl)pyridazine | C5H4F3N3 | 935777-24-5 | Details |
| 4-Chloro-3',4'-dimethoxychalcone | C17H15ClO3 | 177900-49-1 | Details |
| BMS-816336 | C21H27NO3 | 1009583-20-3 | Details |
| Cade oil | 8013-10-3 | Details |
| 2-Methyl-6-quinolinecarboxylic acid | C11H9NO2 | 635-80-3 | Details |
| 5-Cyanopyrazine-2-carboxylic acid | C6H3N3O2 | 1211533-09-3 | Details |
| 3-Bromo-4-methoxyphenylacetic acid | C9H9BrO3 | 774-81-2 | Details |
| 1,3-Bis(2-methoxyphenyl)propane-1,3-dione | C17H16O4 | 142472-15-9 | Details |
| 2-[3-(2,2,2-Trifluoroethoxy)phenyl]ethan-1-amine hydrochloride | C10H13ClF3NO | 1803592-03-1 | Details |
| Topramezone | C16H17N3O5S | 210631-68-8 | Details |
| Lithium 3-phenyl-1,2,4-oxadiazole-5-carboxylate | C9H7LiN2O3 | 1864062-88-3 | Details |
| 2-Methyl-6-(propan-2-yl)pyridine-3-carboxylic acid hydrochloride | C10H14ClNO2 | 1803592-94-0 | Details |
| 6-o-p-Methoxycinnamoylcatalpol | C25H30O12 | 121710-02-9 | Details |
| Ethyl 4-chloro-1,3-dimethylpyrazolo[3,4-b]pyridine-5-carboxylate | C11H12ClN3O2 | 20481-15-6 | Details |
| Molybdenum hexacarbonyl | C6MoO6 | 13939-06-5 | Details |
| 2,4-Dibromo-6-tert-butylphenol | C10H12Br2O | 15460-12-5 | Details |
| 1-{[2-(Aminomethyl)phenyl]methyl}pyrrolidin-3-ol | C12H18N2O | 1340306-85-5 | Details |
| (1R)-1-(5-Fluoro-2-methylphenyl)ethan-1-ol | C9H11FO | 1344907-76-1 | Details |
| 2-(2,5-Dichlorophenoxy)-2-phenylacetic acid | C14H10Cl2O3 | 861065-47-6 | Details |
| G-R-G-D-S-P | C22H37N9O10 | 91037-75-1 | Details |
| (+)-Gymnemic Acid I | C43H66O14 | 122168-40-5 | Details |
| Setipiprant(ACT-129968) | C24H19FN2O3 | 866460-33-5 | Details |
| 5,6-Dihydro-5-methyluridine | C10H16N2O6 | 23067-10-9 | Details |
| 1-(4-tert-Butylphenyl)-5-propyl-1H-1,2,3-triazole-4-carboxylic acid | C16H21N3O2 | 1096911-74-8 | Details |
| 4-Iodo-1-methyl-1H-imidazole | C4H5IN2 | 71759-87-0 | Details |
| 2,3,4-Tri-O-benzyl-b-D-arabinopyranose | C26H28O5 | 18039-26-4 | Details |
| Isoquinoline-5-sulfonamide | C9H8N2O2S | 109547-31-1 | Details |
| 2-(4-Fluorobenzenesulfonamido)ethanimidamide hydrochloride | C8H11ClFN3O2S | 1423034-26-7 | Details |
| Calreticulin 3 antibody | Details |
| Guaimesal | C16H14O5 | 81674-79-5 | Details |
| (4-Bromophenyl)(4-methylpiperazin-1-yl)methanone | C12H15BrN2O | 349395-87-5 | Details |
| N-(4-Trifluoromethylphenyl)-2-chloropropanamide | C10H9ClF3NO | 572881-42-6 | Details |
| trans-Zeatin | C10H13N5O | 1637-39-4 | Details |
| t-boc-N-EDA | C13H27NO6 | 106984-09-2 | Details |
| Ceralifimod | C27H33NO4 | 891859-12-4 | Details |
| N-Methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine hydrochloride | C10H12ClN3O | 1158371-89-1 | Details |
| 5-chloro-3,3-dimethylindolin-2-one | C10H10ClNO | 74492-46-9 | Details |
| (E)-Guggulsterone | C21H28O2 | 39025-24-6 | Details |
| 2-Desmethylbenzaldehyde tolvaptan | C18H19ClN2O2 | 1432725-24-0 | Details |
| [3-(2-Phenylethoxy)phenyl]boronic acid | C14H15BO3 | 1029439-94-8 | Details |
| OTS186935 trihydrochloride | C25H27Cl2N5O2 | 2093401-85-3 | Details |
| H-SAMTNLAAL-OH | Details |
| 4-(Butan-2-yl)-5-phenyl-4H-1,2,4-triazole-3-thiol | C12H15N3S | 1016648-88-6 | Details |
| LY 2922470 | C28H29NO4S | 1423018-12-5 | Details |
| (1R,2S)-2-Phenylcyclopropane-1-carboxylic acid | C10H10O2 | 48126-51-8 | Details |
| 4-Fluoro-3-methanesulfonamidobenzoic acid | C8H8FNO4S | 1184452-50-3 | Details |
| 4-(Chloromethyl)-2,2-difluoro-1,3-dioxaindane | C8H5ClF2O2 | 1435806-39-5 | Details |
| PTGDS antibody | Details |
| KRT2A antibody | Details |
| 3-Hydroxy-7,8-dimethoxyflavone | C17H14O5 | 94393-14-3 | Details |
| MAP3K7 antibody (Ser439) | Details |
| Recombinant SARS-CoV-2 Spike S1-S2 Chimeric Protein | Details |
| 1-Cyclobutyl-2-methylpropan-1-one | C8H14O | 25111-33-5 | Details |
| COL26A1 antibody | Details |
| Synaptophysin 2 antibody | Details |
| 4, 6- O- [(R) - Phenylmethylene] -a- D-glucopyranose | C13H16O6 | 113566-67-9 | Details |
| 2-[2-Oxo-2-(pyrrolidin-1-yl)ethyl]-2H,3H,5H,6H,7H,8H-pyrido[4,3-c]pyridazin-3-one hydrochloride | C13H18N4O2.HCl | 1384427-71-7 | Details |
| Recombinant Mouse HGF R | Details |
| SARS-CoV-2 Antigen Peptide NCAP (ILLNKHID) | Details |
| 1,3,6-Tri-O-benzyl-4-O-(3,6-di-O-acetyl-2,4-dideoxy-2-phthalimido-b-D-glucopyranosyl)-2-deoxy-2-phthalimido-b-D-glucopyranoside | C53H50N2O14 | Details |
| 4-Amino-3,5-dichlorobenzene-1-sulfonyl chloride | C6H4Cl3NO2S | 98141-54-9 | Details |
| SLC27A2 antibody | Details |
| CD8B protein (His tag) | Details |
| (Cyclopropylmethyl)[(2-fluorophenyl)methyl]amine hydrochloride | 1955541-71-5 | Details |
| 5-(3-Fluorobenzamido)-3-methylthiophene-2-carboxylic acid | C13H10FNO3S | 926208-28-8 | Details |
| AP2S1 antibody | Details |
| 2-(3-Chlorophenyl)pentanoic acid | C11H13ClO2 | 1226181-74-3 | Details |
| 4-(Chloromethyl)-2-(cyclobutoxymethyl)thiazole | C9H12ClNOS | 1247108-52-6 | Details |
| H-ETIEQEK^-OH | Details |
| 2-(2-Chloro-4-fluorophenoxy)benzaldehyde | C13H8ClFO2 | 1005763-44-9 | Details |
| SLC12A5 Blocking Peptide | Details |
| N-[1-(2-Bromoacetyl)cyclopentyl]-2,2,2-trifluoroacetamide | C9H11BrF3NO2 | 1564568-43-9 | Details |
| 4-(3-chloro-5-(trifluoromethyl)(2-pyridyl))-1-((4-(trifluoromethoxy)phenyl)sulfonyl)-1,4-diazaperhydroepine | C18H16ClF6N3O3S | 1022400-77-6 | Details |
| Ethyl 2-(2-chloropropanamido)-5-ethylthiophene-3-carboxylate | C12H16ClNO3S | 1097782-77-8 | Details |
| 2-Phenylpropane-2-d1 | C9H11D | 4019-54-9 | Details |
| 1,3,4,6-Tetra-O-acetyl-α-D-glucosamine hydrochloride | C14H22ClNO9 | 10034-19-2 | Details |
| 4-(4-Aminobutyl)pyridin-2-amine dihydrochloride | 2138249-46-2 | Details |
| Cannflavin C | C26H28O6 | 1086463-05-9 | Details |
| Talquetamab | 2226212-40-2 | Details |
| N-(Propan-2-yl)(tert-butoxy)carbohydrazide | C8H18N2O2 | 175233-53-1 | Details |
| (2R)-2-Amino-1-(2,3-dihydro-1H-isoindol-2-yl)propan-1-one hydrochloride | C11H15ClN2O | 1807901-39-8 | Details |
| 2-[Benzyl(methyl)amino]butanoic acid hydrochloride | C12H18ClNO2 | 1803560-77-1 | Details |
| MARCKS antibody (Ser158) | Details |
| 3-Ethyl-3-methyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine dihydrochloride | C12H19ClN2 | 1803587-58-7 | Details |
| 2-Azabicyclo[2.2.2]octane-6-carboxylic acid hydrochloride | 1864058-35-4 | Details |
| 1,7-Dioxaspiro[4.4]non-2-en-4-one | C7H8O3 | 2138204-48-3 | Details |
| Ethyl 3-(pyridin-3-yl)-1H-1,2,4-triazole-5-carboxylate | C10H10N4O2 | 1343270-71-2 | Details |
| 2-(Diethylamino)ethyl 3-amino-4-ethoxybenzoate hydrochloride | C15H25ClN2O3 | 69781-24-4 | Details |
| 2-Ethyl-1-fluoro-4-nitrobenzene | C8H8FNO2 | 1369854-05-6 | Details |
| 5-(Iodomethyl)-4,4-dimethylpyrrolidin-2-one | C7H12INO | 2138562-21-5 | Details |
| 2-(1-Methyl-1H-pyrazol-5-yl)propan-2-amine dihydrochloride | C7H14ClN3 | 2225144-69-2 | Details |
| 2,4,6-Tri-O-acetyl-3-O-benzyl-a-D-glucopyranosyl bromide | C19H23BrO8 | 34339-69-0 | Details |
| 1-Chloro-1,1-difluoro-3-iodopropane | C3H4ClF2I | 1909309-69-8 | Details |
| Biot-PEETQTQDQPME-NH2 | Details |
| Product Total： Product Page： | ||||
| 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 | ||||